Mekke, Joost M.
Sakkers, Tim R.
Verwer, Maarten C.
van den Dungen, Noortje A. M.
Song, Yipei
Miller, Clint L.
Finn, Aloke V.
Pasterkamp, Gerard
Mokry, Michal
den Ruijter, Hester M.
Vink, Aryan
de Kleijn, Dominique P. V.
de Borst, Gert J.
Haitjema, Saskia
van der Laan, Sander W.
Funding for this research was provided by:
EU H2020 Taxinomisis (755320)
Fondation Leducq (PlaqOmics)
Dutch Heart Foundation (CVON-GENIUS-2)
Article History
Received: 26 February 2023
Accepted: 22 September 2023
First Online: 10 October 2023
Competing interests
: Dr. Sander W. van der Laan has received Roche funding for unrelated work; Roche had no involvement whatsoever in any aspect of this study. Dr. Aloke V Finn has received consultant fees/honoraria from Abbott Vascular, Amgen, Biosensors, Boston Scientific, Celonova, Cook Medical, CSI, Lutonix Bard, Sinomed. and Terumo Corporation. They had no involvement whatsoever in any aspect of this study. AV Finn is an employees of the CVPath Institute which has received GranuResearch/Clinical Trial support from NIH-HL141425, Leducq Foundation Grant, 4C Medical, 4Tech, Abbott Vascular, Ablative Solutions. Absorption Systems, Advanced NanoTherapies, Aerwave Medical, Alivas, Amgen. Asahi Medical, Aurios Medical, Avantec Vascular, BD, Biosensors, Biotronik, Biotyx Medical, Bolt Medical, Boston Scientific, Canon USA, Cardiac Implants, Cardiawave, CardioMech, Celonova, Cerus EndoVascuIar, Chansu Vascular Technologies, Childrens National Medical Center, Concept Medical, Cook Medical, Cooper Health, Cormaze Technologies GmbH, CRL/AcceILab, Croivalue, CSI, Dexcom, Edwards Lifesciences, Elucid Bioimaging, eLum Technologies, Emboline, Endotronix, Envision, Filterlex, Imperative Care, Innovalve, Innovative Cardiovascular Solutions, Intact Vascular, Interface Biolgics, Intershunt Techtnologies, Invatin Technologies, Lahav CRO, Limflow, L&J Biosciences, Lutonix, Lyra Therapeutics, Mayo Clinic, Maywell, MD Start, MedAIIiance, Medanex, Medtronic, Mercator, Microport, Microvention, Neovasc, Nephronyx, Nova Vascular, Nyra Medical, Occultech, Olympus, Ohio Health, OrbusNeich, Ossio, Phenox, Pi-Cardia, Polares Medical, Polyvascular, Profusa, ProKidney LLC, Protembis, Pulse Biosciences, Qool Therapeutics, Recombinetics, Recor Medical, Regencor, Renata Medical, Restore Medical, Ripple Therapeutics, Rush University, Sanofi, Shockwave, Sahajanand Medical Technologies, SoundPipe, Spartan Micro, Spectrawave, Surmodics, Terumo Corporation, The Jacobs Institute, Transmural Systems, Transverse Medical, TruLeaf Medical, UCSF, UPMC, Vesper, Vetex Medical, Whiteswell, WL Gore, and Xeltis.